Recon: FDA grants breakthrough designation to gen AI radiology tools; Oncology paper retraction casts doubt on China research
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing. Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, biopharma,…
Read on Raps ↗